DaVita Total Current Assets 2010-2024 | DVA

DaVita total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • DaVita total current assets for the quarter ending June 30, 2024 were $3.467B, a 15.49% increase year-over-year.
  • DaVita total current assets for 2023 were $3.138B, a 0.55% decline from 2022.
  • DaVita total current assets for 2022 were $3.155B, a 0.39% decline from 2021.
  • DaVita total current assets for 2021 were $3.168B, a 0.6% increase from 2020.
DaVita Annual Total Current Assets
(Millions of US $)
2023 $3,138
2022 $3,155
2021 $3,168
2020 $3,149
2019 $3,690
2018 $8,424
2017 $8,771
2016 $3,995
2015 $4,503
2014 $3,636
2013 $3,472
2012 $2,887
2011 $2,293
2010 $2,623
2009 $2,303
DaVita Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $3,467
2024-03-31 $3,684
2023-12-31 $3,138
2023-09-30 $3,135
2023-06-30 $3,002
2023-03-31 $3,040
2022-12-31 $3,155
2022-09-30 $3,202
2022-06-30 $3,264
2022-03-31 $3,129
2021-12-31 $3,168
2021-09-30 $3,840
2021-06-30 $3,979
2021-03-31 $3,867
2020-12-31 $3,149
2020-09-30 $3,430
2020-06-30 $5,780
2020-03-31 $4,024
2019-12-31 $3,690
2019-09-30 $3,999
2019-06-30 $6,391
2019-03-31 $9,225
2018-12-31 $8,424
2018-09-30 $8,930
2018-06-30 $9,085
2018-03-31 $8,674
2017-12-31 $8,771
2017-09-30 $4,034
2017-06-30 $4,024
2017-03-31 $4,604
2016-12-31 $3,995
2016-09-30 $4,261
2016-06-30 $4,496
2016-03-31 $4,200
2015-12-31 $4,503
2015-09-30 $4,738
2015-06-30 $4,781
2015-03-31 $4,301
2014-12-31 $3,636
2014-09-30 $4,178
2014-06-30 $4,161
2014-03-31 $3,707
2013-12-31 $3,472
2013-09-30 $3,381
2013-06-30 $3,132
2013-03-31 $3,191
2012-12-31 $2,887
2012-09-30 $2,326
2012-06-30 $2,179
2012-03-31 $2,374
2011-12-31 $2,293
2011-09-30 $2,370
2011-06-30 $2,513
2011-03-31 $2,727
2010-12-31 $2,623
2010-09-30 $2,262
2010-06-30 $2,265
2010-03-31 $2,461
2009-12-31 $2,303
2009-09-30 $2,309
2009-06-30 $2,233
2009-03-31 $2,031
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $13.689B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00